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Naturally occurring substituted imidazoles as well as synthetic
derivatives thereof exhibit a wide range of biological activities,
making them attractive compounds for biochemists and organ-
ic chemists. Imidazoles act as inhibitors of p38 MAP kinase
(Lee et al., 1994), B-Raf kinase (Takle et al., 2006), cyclooxy-
genase-2 (COX-2) (Lange et al., 2005), transforming growth
factor b1 (TGF-b1) and type-1 activin receptor-like kinase
(ALK5) Khanna et al., 1997 and are useful in the biosynthesis
of interleukin-1 (IL-1) Gallagher et al., 1995. Substituted imi-
dazoles are extensively used as glucagon receptors (de Laszlo
et al., 1999) and CB1 cannabinoid receptor antagonists (Eyers
et al., 1998), modulators of P-glycoprotein (P-gp)-mediated(M.A. Pasha).
ity.
lseviermultidrug resistance (MDR) Newman et al., 2000, act as anti-
bacterials (Antolini et al., 1999) and also as antitumor (Wang
et al., 2002) agents. Recent advances in green chemistry and
organometallic catalysis has extended the application of imida-
zoles as ionic liquids (Dupont et al., 2002) and as N-heterocy-
clic carbenes (Bourissou et al., 2000; Arnold and Liddle, 2006;
Kuhl, 2007). Highly substituted imidazoles are expected to
have potential therapeutic activities (Lee et al., 1994).
Methods are available in the literature for the synthesis of
imidazoles; to mention a few: 2,4,5-trisubstituted imidazoles
are synthesized by a three component cyclocondensation of a
1,2-diketone, or a-hydroxyketone, or an a-ketomonoxime with
an aldehyde and ammonium acetate in the presence of cata-
lysts such as ionic liquids (Siddiqui et al., 2005), silica–sulfuric
acid (Shaabani and Rahmati, 2006), and NiCl2Æ6H2O/Al2O3
(Heravi et al., 2007). 1,2,4,5-Tetrasubstituted imidazoles, on
the other hand, are prepared by a four component reaction
of a 1,2-diketone, or an a-hydroxyketone, or a-ketomonoxime
with an aldehyde, aniline and ammonium acetate in the pres-
ence of catalysts such as InCl3Æ3H2O (Das Sharma et al.,
2008) and ZrCl4 (Sharma et al., 2006). The developed proce-
dures have both advantages and disadvantages, such as the
use of expensive reagents and the environmental hazards asso-
ciated with their use and prolonged reaction time.
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Table 1 p-TSA catalysed synthesis of 1,2,4,5-tetraaryl-imidazoles.
Entry Aldehyde Product (5)a Reaction time (min) Yield (%)b
a. CHO
N
N
Ph
Ph
Ph 30 92
b.
CHO
OCH3
N
N
Ph
Ph
Ph
OCH3 35 90
c.
Cl
CHO
N
N
Cl
Ph
Ph
Ph
40 87
d.
OH
CHO
N
N
HO
Ph
Ph
Ph
40 85
e.
CHO
NO2
N
N
Ph
Ph
Ph NO2
45 80
f.
CHO
NO2
N
N
Ph
Ph
Ph
NO2 45 80
g.
OH
CHO
N
N
OH
Ph
Ph
Ph
40 85
h.
CHO
OCH3
OCH3
H3CO
N
N
Ph
Ph
Ph OCH3
OCH3
OCH3
40 89
a5a, 5e and 5h were characterized by 1H NMR and IR spectral analysis. 5b, 5c, 5d, 5f and 5g were characterized by comparison on TLC or by
their melting points with authentic samples prepared by the reported method (Mazaahir and Poonam, 2006).
bIsolated yields.
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Scheme 2
p-TSA catalysed efﬁcient synthesis 57As noticed, imidazoles are of enormous biological impor-
tance, and we feel that there is a need to synthesize these mole-
cules using simple, readily available and less expensive
catalysts in shorter duration of time.We, in our laboratory, have
been working on the development of procedures, which can be
used to synthesize biologically active molecules using simpler
methodologies and readily available catalysts (Pasha and
Madhusudana Reddy, 2009; Pasha and Jayashnkara, 2006a,b;
Pasha and Nanjundaswamy, 2007). As well known, p-TSA
(Xiangming and Huiqiang, 2007) has been used as a mild acidic
catalyst to synthesize a number of benzimidazoles, and in our
laboratory, we have used p-TSA to synthesize 1,5-benzodiaze-
pines (Pasha and Jayashnkara, 2006a), bis(indolyl) methanes
Pasha and Jayashnkara, 2006b, novel quinolines (Pasha et al.,
2008), acylals (Pasha and Manjula, 2007) and nitriles (Pasha
et al., 2009). Hence, as an alternative, we planned to use
p-TSA for the synthesis of 1,2,4,5-tetraaryl-imidazoles from
benzoin (1), araldehyde (2), aniline (3) and ammonium acetate
(4) as shown in Scheme 1.
2. Results and discussion
1,2,4,5-Tetraphenyl imidazole (5) was prepared in quantitative
yield by condensing benzoin, aniline, and ammonium acetate
with benzaldehyde in the presence of p-TSA as a catalyst in
ethanol as solvent after 30 min. The separated solid was ﬁl-
tered and recrystallized to get the pure product. To optimize
the reaction conditions, the reactions were carried out using
catalysts such as Zn(OAc)2Æ2H2O and ClSO3H; due to unsatis-
factory results, these catalysts were rejected. Then, the reaction
was carried out using an organo-catalyst p-TSA, and positive
results were obtained. Encouraged by this, p-TSA was used
as a model catalyst for further reactions. Optimization of thereaction was done by using different amounts of p-TSA
[2 mol%, 5 mol% and 10 mol%], and high yield of the product
was obtained with 10 mol% of the catalyst. These optimized
conditions were applied to get imidazoles from a series of
substituted araldehydes and the results of these studies are pre-
sented in Table 1. From this table, it is clear that irrespective of
the substituents present on the araldehydes the yields of imida-
zoles did not vary much.
2.1. Mechanism
The reaction can be mechanistically considered to proceed
with the protonation of the araldehydes by p-TsOH and the
subsequent attack by ammonia from ammonium acetate and
aniline to give C,N-diphenyl-methanediamine (A), which may
react with benzoin in the presence of p-TsOH to afford dihy-
droimidazole (B), followed by aerial oxidation (Hoang et al.,
2001) to give the product as shown in Scheme 2.
3. Experimental
Yields refer to isolated products after puriﬁcation. The IR
spectra were taken using KBr pellets. IR and 1H NMR spectra
were recorded on SHIMADZU FT-IR-8400s and Bruker (300-
MHz) spectrophotometers, respectively. The purity of the sub-
stances and the progress of the reactions were checked on
TLC. The reagents used were all commercial and used without
any puriﬁcation.
3.1. General procedure for the preparation of tetrasubstituted
imidazoles
A mixture of benzoin (0.42 g, 5 mmol), aniline (0.47 g,
5 mmol), ammonium acetate (0.38 g, 5 mmol) and araldehyde
(5 mmol) was taken in ethanol (10 ml), to which p-TSA
(0.19 g, 1 mmol) was added. The reaction mixture was then re-
ﬂuxed for 3060 min. In some cases a solid separated which
was ﬁltered and in cases where solid did not separate, cold
water (10 ml) was added to get the solid. The crude products
were then subjected to further puriﬁcation either by recrystal-
lization from EtOH or by silica gel column chromatography.
3.2. Spectral studies of 2-(3-nitrophenyl)-1,4,5-triphenyl-
imidazole (5e)
The formation of yellow solid 2-(3-nitrophenyl)-1,4,5-
triphenyl-imidazole was conﬁrmed by the melting point
[245–246 C (Lit. m.p. 244–246 C)]. IR spectrum showed
characteristic peaks at 1598 cm1 for C‚C and at 1575 cm1
for C‚N. The 1H NMR spectrum supported the structure
of 2-(3-nitrophenyl)-1,4,5-triphenyl-imidazole showing a mul-
tiplet between d 7.10–8.96 ppm for aromatic protons.
4. Conclusion
In conclusion, we report a simple, mild and efﬁcient method
for the preparation of the 1,2,4,5-tetraarylimidazoles. The re-
agents used here are readily available, less expensive and easy
to handle. The procedure reported herein is not cumbersome;
consequently, the methodology represents a good addition to
the list of methods available for the synthesis of highly substi-
tuted imidazoles.
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